Fundraising FoxEnodia Therapeutics
4 known investors
Find your way into Enodia Therapeutics
Sign up to see every warm intro you have to Enodia Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Enodia Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Enodia Therapeutics develops small-molecule therapies that target protein degradation at the point of synthesis using a machine learning-enabled platform. The company serves the therapeutic development market with its targeted protein degradation approach.
Founders & leadership
YR
Yves RibeillCEO
Investors · 4
Bpifrance✓ confirmed by Enodia TherapeuticsParis, Ile-De-France · $270K
How we know: the company's own site · Not right? Tell us
Elaia✓ confirmed by Enodia TherapeuticsParis · $108K – $1.6M
How we know: the company's own site · Not right? Tell us
Pfizer Ventures✓ confirmed by Enodia Therapeutics
How we know: the company's own site · Not right? Tell us
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Enodia Therapeutics do?
- Enodia Therapeutics develops small-molecule therapies that target protein degradation at the point of synthesis using a machine learning-enabled platform. The company serves the therapeutic development market with its targeted protein degradation approach.
- Who are Enodia Therapeutics's investors?
- Enodia Therapeutics's investors include Bpifrance, Elaia, Pfizer Ventures, Pfizer Venture Investments.